CONFERENCES AND ABSTRACTS (*with presentation).

Adam Telerman and Robert Amson.
American Association for Cancer Research (AACR) Annual Meeting, Philadelphia, April 2015.
 
Adam Telerman and Robert Amson.
Mechanisms & Models of Cancer
Cold Spring Harbor, August 2014.
 
Robert Amson, Andrea Senff Ribeiro, Salvatore Pece, Pier Paolo Di Fiore Judith E Karp, Jean-Christophe Marine and Adam Telerman.Tumor reversion: from bench to potential clinical applications using Sertraline and Thioridazine.
American Association for Cancer Research (AACR) Annual Meeting, Washington, April 2013* 
 
Robert Amson, Salvatore Pece, Alexandra Lespagnol, Rajesh Vyas, Giovanni Mazzarol, Daniela Tosoni, Ivan Colaluca, Giuseppe Viale, Sylvie Rodrigues-Ferreira, Jessika Wynendaele, Olivier Chaloin, Johan Hoebeke, Jean Christophe Marine, Pier Paolo Di Fiore, and Adam Telerman.
TCTP promotes MDM2-mediated ubiquitination and degradation of p53
Sixth International Mdm2 Workshop, New York October 2012 *

Robert Amson, Salvatore Pece, Alexandra Lespagnol, Rajesh Vyas, Giovanni Mazzarol, Daniela Tosoni, Ivan Colaluca, Giuseppe Viale, Sylvie Rodrigues-Ferreira, Jessika Wynendaele, Olivier Chaloin, Johan Hoebeke, Jean-Christophe Marine, Pier Paolo Di Fiore and Adam Telerman. 
Relevance of the repressive feedback loop between p53 and TCTP in stemness and cancer treatment.
Mechanisms & Models of Cancer 2011
Salk Institute for Biological Studies, La Jolla, CA, August 2011*

Telerman and R. Amson.
The biology of Cancer: microenvironment, metastasis & therapeutics
Cold Spring Harbor, April 2011.

R. Amson., A.Telerman and Christian Auclair.
Tumor reversion program
Annual meeting of Conticanet (European Connective Tissue Network) Paris January 2011*.

Robert Amson, Salvatore Pece, Alexandra Lespagnol, Giovanni Mazzarol, Sylvie Rodriguez-Ferreira, Daniela Tosoni, Ivan Colaluca, Jean-Christophe Marine, Olivier Chaloin, Johan Hoebeke , Pier Paolo Di Fiore, and Adam Telerman. 
New molecular insights into a key role for TCTP in tumorigenesis and tumor reversion.
Mechanisms & Models of Cancer
Cold Spring Harbor, August 2010*.

R. Amson., A.Telerman and Christian Auclair.
Tumor reversion program
Annual meeting of Conticanet (European Connective Tissue Network) ,Institut Curie January 2010*.

A. Telerman and R. Amson.
Mechanisms and Models of Cancer. 
Salk Institute for Biological Studies, La Jolla, CA, August 2009

R. Amson., A.Telerman and Christian Auclair.
Tumor reversion program
Annual meeting of Conticanet (European Connective Tissue Network) Leuven, Belgium, January 2009*.

R. Amson., A.Telerman and Christian Auclair.
Tumor reversion program
Meeting of Conticanet (European Connective Tissue Network) Stockholm, Sweden, September 2008*.

A. Lespagnol, C. Beekman, L. Blanc, J.C. Marine, M. Vidal, R. Amson and A. Telerman.
TSAP6/STEAP3 regulates p53-dependent secretion of exosomes     
Mechanisms & Models of Cancer
Cold Spring Harbor, August 2008*.

R. Amson, A. Lespagnol, O. Chaloin, J. Hoebeke and A. Telerman.
Inhibition of the interaction  between TSAP6 and TCTP promotes cell death.         
Mechanisms & Models of Cancer
Cold Spring Harbor, August 2008*.

A. Telerman and R. Amson.
PTEN Meeting
Cold Spring Harbor, March 2008

A. Telerman and R. Amson.
Cell Death
Cold Spring Harbor, September 2007

A. Telerman and R. Amson.
Mechanisms and Models of Cancer.
Foundation for Advanced Cancer Studies.
Salk Institute La Jolla, CA, August 2007

A. Telerman and R. Amson.
Mechanisms & Models of Cancer
Cold Spring Harbor, August 2006

A. Telerman and R. Amson.
3rd International Mdm2 Workshop.
Konstanz, September 2005.
 
A. Telerman and R. Amson.
Tumor reversion as an alternative approach in cancer research: biological models,
molecular pathways and identification of target proteins for potential cancer therapies.
LXX Cold Spring Harbor Symposium on quantitative Biology
Molecular Approaches To Controlling Cancer.
Cold Spring Harbor, June 2005*.

B. Passer, C.Cans, V. Nancy-Portebois, V. Crible, R. Amson, and A. Telerman.
TCTP regulates the activity of the microtubule destabilizing protein.
Cancer Genetics & Tumor Suppressor Genes.
Cold Spring Harbor, August 2004*.

B. Passer, N. Amzallag, D. Allanic, E. Segura, C. Théry, B. Gould, R. Amson and
A. Telerman.
TSAP6 facilitates the secretion of TCTP/HRF via a non-classical pathway.
Cancer Genetics & Tumor Suppressor Genes.
Cold Spring Harbor, August 2004*.

B. Passer, Amson and A. Telerman.
Conference on Programmed cell death.
Cold Spring Harbor, September 2003.

M. Tyunder, L. Susini, S. Prieur, S. Besse, N. Privat, R. Amson and A. Telerman.
Biological models and genes of tumor reversion : cellular reprogramming through inhibition of TPT1/TCTP.
Cancer Genetics & Tumor Suppressor Genes.
Cold Spring Harbor, August 2002*.

M. Tuynder, L. Susini, J. Richardson, L. Goodman, B. Bowen, A. Géant, M. Oren,
R. Amson and A. Telerman.
Characterization of biological models and molecular pathways of tumor reversion: cross-talk with programmed cell death.
Conference on Programmed cell death.
Cold Spring Harbor, September 2001*.

L. Susini, B. Passer, N. Amzallag-Elbaz, T. Juven-Gershon, S. Prieur, N. Privat, M. Tuynder, M. Oren, R. Amson and A.Telerman.
SIAH binds and regulates the function of Numb.
Conference on Programmed cell death.
Cold Spring Harbor, September 2001*.

B. Passer, S. Prieur, A. Roborel de Climens, V. Nancy-Portebois, N. Privat, N. Amzallag-Elbaz, R. Amson and A.Telerman.
The p53-inducible TSAP6 gene product interacts with Nix and the Myt1 kinase : Implications of  apoptosis and the cell control.
Conference on Programmed cell death.
Cold Spring Harbor, September 2001*.

M. Tuynder, L. Susini, J. Richardson, L. Goodman, , A. Géant, F. Dufour, E. Mas, S. Zyto, J. Tolédano, M. Oren, S. Brenner, R. Amson and A. Telerman.
Characterisation of biological models and molecular pathways of tumor reversion.
Annual Meeting on Oncogenes, Frederick, Maryland, USA, June 2001*.

M. Tuynder, F. Lethrosne, S. Prieur, J.P. Roperch, L. Susini, M. Oren, and A. Telerman.
Uncovering tumor suppression pathways by investigationg tumor reversion.
Conference on cancer genetics & tumor suppressor genes.
Cold Spring Harbor, August 2000*.

J.P. Roperch, F. Lethrosne, S. Prieur, D. Israeli, L. Piouffre, M. Nemani, P. Pasturaud, J. Dausset, M. Oren, R. Amson, and A. Telerman.
Siah-1 promotes apoptosis and tumor suppression through a network involving the regulation of protein folding, unfolding and trafficking : identification of common effectors with p53 and p21waf1
Fifteenth annual meeting on oncogenes and tumor suppressors, June 1999*.

R. Amson, M. Lassalle, H. Halley, C.. Duyckaerts, J.P. Roperch, S. Prieur, D. Israeli, F. Lethrosne, L. Piouffre, F. Checler, J. Dausset, M. Oren, and A. Telerman.
Apoptosis in the brains of p53 knock-out mice : a presenilin1-dependent mechanism with memory and behavioural alterations.
Conference on programmed cell death.
Cold Spring Harbor, October 1999*.

R. Amson, J.P. Roperch, V. Alvaro, M. Nemani, S. Prieur, M. Tuynder, G. Linares-Cruz, H. Bruzzoni-Giovanelli, F. Lethrosne, L. Piouffre, D. Israeli, F. Calvo, M. Oren and A. Telerman.
The humsiah 1 and presenilin 1 genes are active components of a complex network regulating tumor suppression and apoptosis.
Conference on cancer genetics & tumor suppressor genes.
Cold Spring Harbor, August 1998*.

M. Nemani , J.P. Roperch, S. Prieur, M. Tuynder, F. Lethrosne, L. Piouffre, V. Alvaro, F. Calvo, D. Israeli, M. Oren, R. Amson, and A. Telerman.
Presenilin 1 at the crossroad of alzheimer’s disease and cancer
Conference on programmed cell death.
Cold Spring Harbor, September 1997*.

G. Linares-Cruz, H. Bruzzoni-Giovanelli, V. Alvaro, J.P. Roperch, M. Tuynder, D. Schoevaert, M. Nemani, M. Medhioub, D. Chassoux, J. Dausset, R. Amson, F. Calvo and A. Telerman.
P21 waf1 reorganizes the nucleus in tumor suppression
Cancer genetics and tumor suppressor genes conference, June 1997*.

A. Telerman, M. Nemani, J.P. Roperch, G. Lineares Cruz, H. Bruzzoni Giovanelli, V. Alvaro, D. Israeli, M. Medhioub, L. Bougueleret, D. Cherif, D. Le Paslier , I. Le Gall, J. Dausset, F. Calvo, M. Oren, D. Cohen and R. Amson.
The human homologue of the Drosophila seven in absentia gene in apoptosis and tumor suppression.
Twelfth Annual Meeting on Oncogenes, Frederick, Maryland, USA, June 1996*.

A. Telerman and R. Amson.
The cell cycle.
Keystone Symposium, Taos, New Mexico, January 1996.

A. Telerman and R. Amson.
Conference on Programmed cell death.
Cold Spring Harbor, September 1995.

A. Telerman, M. Tuynder, T. Dupressoir, B. Robaye, F. Sigaux, E. Shaulian, M. Oren, J. Rommelaere and R. Amson.
A model for tumor suppression using H-1 parvovirus.
5th Parvovirus Workshop, Crystal River, Florida, USA, November 1993*.

A. Telerman, M. Tuynder, T. Dupressoir, B. Robaye, F. Sigaux, E. Shaulian, M. Oren, J. Rommelaere and R. Amson.
Selection of a suppressed phenotype in a human leukemia by means of H-1 parvovirus.
Ninth Annual Meeting on Oncogenes, Frederick, USA, June 1993*.

R. Amson, F. Sigaux, S. Przedborski and A. Telerman
Expression of the p33pim during human fetal hematopoiesis and in leukemias.
EMBL Conference, Oncogenes and Growth Control, Heidelberg, April 1990*.

A. Telerman, F. Sigaux, S. Przedborski, J-P. Brion, P. Van Oostveldt, G. Flandrin, D. Givol and R. Amson
Expression of the p33pim during human fetal hematopoiesis and in leukemias.
Fifth Annual Meeting on Oncogenes, Frederick, June 1989*.

A. Telerman and R. Amson.
Cold Spring Harbor Symposium on Quantitative Biology
Molecular Biology of Signal Transduction.
Cold Spring Harbor, June 1988.

A. Telerman, R. Amson, R. Zakut-Houri and D. Givol
Characterization of the human pim-1 oncogene and its 33 Kd tyrosine kinase protein product.
Fourth Annual Meeting on Oncogenes. Frederick,June I988, National Cancer Inst. *.

R. Zakut Houri, S. Hazum, D. Givol and A. Telerman
cDNA sequence and gene analysis of the human pim oncogene.
EMBL Conference: Oncogene and Growth Control.Heidelberg I987 *.
 
R. Amson, C. Marcel , N. Taylor, B. Lifshitz, E. Feinstein, A. Telerman, E. Shtivelman, R.P. Gale
    and E. Canaani
Bcr gene transcripts.
Oncogene Meeting, National Cancer Inst. Maryland (1987)*.

R. Amson, C. Marcel, N. Taylor, A. Telerman and E. Canaani
Identification of a bcr gene product.
EMBL Conference:Oncogene and Growth Control.Heidelberg 1987*.

A. Telerman , R. Mosselmans, R. Amson, F. Romasco, E. Dupont, P. Galand,
and J. Wybran
Internalization of the T3 differentiation antigen after binding with monoclonal OKT3 antibody.
Proceedings of the 7th  European Immunology Meeting (1985)*.

A. Telerman, J. Squires, F. Sarkar, S. Gupta and C.D. Platsoucas
Chemical crosslinking of the T3 antigen with the beta chain of the T cell  receptor.
Proceedings of the 7th European Immunology Meeting (1985) *.

A. Telerman, F. Sarkar, J. Kunicka, S. Gupta and C.D. Platsoucas
Crosslinking of the T3 antigen with other cell surface molecules.
American Society of  Experimental Biology (1985).
 
A. Telerman, S. Kempin, M. Isaacs, F. Chae, S. Ellis and B. Clarkson
Effect of renal failure upon treatment of Acute Nonlymphocytic Leukemia.
American Society of Hematology,26th Meeting, Miami (1984).

A. Telerman R. Amson, M. Deschuyteneer, R. Mosselmans, J-P Perraudin,
P. Strijckmans and J-P Prieels
Galactosyltransferase/Sialyltransferase activity as an index of membrane glycosylation of
lymphocyte subpopulations.
Proceedings of the Colloquium on the Protides of the Biological Fluids.Brussels,1984*.

R. Amson, A. Telerman, M. Deschuyteneer, R. Mosselmans, J-P Perraudin, P. Strijckmans and J-P Prieels
Comparison of the interaction of lactoferrin with hepatocytes,lymphocytes and monocytes.
Proceedings of the Colloquium on the Protides of the Biological Fluids.Brussels 1983*.

A. Telerman, H. Bleiberg, B. Van den Heule and A. Gérard
Metastases to the gastrointestinal wall.
Meeting Gastroenterology.Brussels 1981*.
 
A. Telerman, R. Amson, A. Delforge, E. Collard and P. Strijckmans
Chronic aneosinocytosis.
Proceedings of the International Meeting of Hematology.Montréal 1980*.